J
Joshua D. Lee
Researcher at New York University
Publications - 106
Citations - 2951
Joshua D. Lee is an academic researcher from New York University. The author has contributed to research in topics: Buprenorphine & Opioid use disorder. The author has an hindex of 24, co-authored 92 publications receiving 2279 citations. Previous affiliations of Joshua D. Lee include Columbia University Medical Center & Columbia University.
Papers
More filters
Journal ArticleDOI
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Joshua D. Lee,Edward V. Nunes,Patricia Novo,Ken Bachrach,Genie L. Bailey,Snehal Bhatt,Sarah Farkas,Marc Fishman,Phoebe Gauthier,Candace C. Hodgkins,Jacquie King,Robert Lindblad,David Liu,Abigail G. Matthews,Jeanine May,K Michelle Peavy,Stephen Ross,Dagmar Salazar,Paul Schkolnik,Dikla Shmueli-Blumberg,D. Stablein,Geetha Subramaniam,John Rotrosen +22 more
TL;DR: It is more difficult to initiate patients to XR-NTX than BUP-NX, and this negatively affected overall relapse, but once initiated, both medications were equally safe and effective.
Journal ArticleDOI
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
Joshua D. Lee,Peter D. Friedmann,Timothy W. Kinlock,Edward V. Nunes,Tamara Y. Boney,Randall Hoskinson,Donna Wilson,Ryan McDonald,John Rotrosen,Marc N. Gourevitch,Michael S. Gordon,Marc Fishman,Donna T. Chen,Richard J. Bonnie,James W. Cornish,James W. Cornish,Sean M. Murphy,Charles P. O'Brien +17 more
TL;DR: In this trial involving criminal justice offenders, extended-release naltrexone was associated with a rate of opioid relapse that was lower than that with usual treatment, and Opioid-use prevention effects waned after treatment discontinuation.
Journal ArticleDOI
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial
Stephen Magura,Joshua D. Lee,Jason Hershberger,Herman Joseph,Lisa A. Marsch,Carol Shropshire,Andrew Rosenblum +6 more
TL;DR: After initiating opioid agonist treatment in jail, continuing buprenorphine maintenance in the community appears to be more acceptable to offenders than continuing methadone maintenance.
Journal ArticleDOI
Do internists, pediatricians, and psychiatrists feel competent in obesity care?: using a needs assessment to drive curriculum design.
Melanie Jay,Colleen Gillespie,Tavinder K. Ark,Regina Richter,Michelle McMacken,Sondra Zabar,Steven Paik,Mary Jo Messito,Joshua D. Lee,Adina Kalet +9 more
TL;DR: A survey demonstrated a critical need for training in specific areas of obesity care, and the proposed curriculum targets these areas taking into consideration observed differences across specialties.
Journal ArticleDOI
Home Buprenorphine/Naloxone Induction in Primary Care
TL;DR: Induction complications occurred at expected rates and were not associated with short-term treatment drop-out, and buprenorphine induction was feasible and appeared safe.